Rashna Madan
University of Kansas Medical Center(US)
Publications by Year
Research Areas
Extracellular vesicles in disease, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Cancer Immunotherapy and Biomarkers, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer(2023)144 cited
- → Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells(2016)109 cited
- → Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma(2005)88 cited
- → ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance(2005)65 cited
- → Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: Cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma(2006)60 cited
- → Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics(2013)53 cited
- → Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).(2022)51 cited
- → Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer(2019)49 cited
- → Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells(2014)49 cited
- → A novel 4.1 ezrin radixin moesin (FERM)‐containing protein, ‘Willin’(2005)44 cited